Figure 1.
Kaplan–Meier plot comparing time from diagnosis to first treatment (a) and progression‐free survival (b) between immunoglobulin variable region heavy chain (IGHV) mutated and unmutated chronic lymphocytic leukemia (CLL) patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.